ADVANCE infectious diseases pharmacy through collaboration, research and education and LEAD antimicrobial stewardship to OPTIMIZE the care of patients with infections in every practice setting

Forgot password


  • Home
  • COVID-19 Monoclonal Antibody Toolkit
COVID-19 Monoclonal Antibody Toolkit

This toolkit was last updated 1/1/2023 and is no longer being reviewed for accuracy and updates. Resources should be used with caution, as content may be outdated.

SIDP has developed COVID-19 Monoclonal Antibody (mAb) Toolkits for Treatment, Post-Exposure Prophylaxis (PEP) and Pre-Exposure Prophylaxis (PrEP) informed by the experiences of pharmacists who have implemented mAb infusions for COVID-19 patients at their institutions.

Toolkit Features:

  • Tools to guide development of a mAb infusion process, regardless of infusion site (e.g., Emergency Department, integrated infusion center, free standing infusion center)
  • Information on available mAb products and compounding guidance
  • Resources for nursing, providers, and patients
  • Specific guidance on use of mAbs in pediatric patients 

SIDP member, Nick Piccicacco, PharmD (right) discussing mAb therapeutics with a physician colleague

Toolkit Contents

COVID-19 mAb Survey Results

Input from SIDP members and other healthcare providers on mAb implementation barriers and successes 

Developing an Infusion Process

Graphics describing the make-up of the mAb team

Resources to establish, market, operate, and assess an infusion center for mAb treatment, PEP and PrEP

Products and Compounding Resources

Product Comparison Table

Compounding and Administration Guides

Example Orders and Order Sets

Provider and Patient Resources

For both adult and pediatric patients!

Nursing Resources

Staff education presentation and guidelines for managing infusions

Clinical Data & Useful Links

Compendium of links to relevant external mAb content for treatment, PEP and PrEP




Claim CE for reviewing this toolkit

Note: This CE counts for PREP Act requirements

Register to Access Toolkit Resources

Sign-up as a Registered Resource User of this free content in order to access toolkit materials and be alerted by SIDP as new revisions/updates emerge.  Of note, this content is publicly available at no cost.  SIDP membership is not required to register as a toolkit user.

SIDP will not share any contact information provided with any third party and

will only contact registered resource users with information pertaining to educational resources

Once you have signed up as a Registered Resource User, access the toolkit resources using the link below!

Note, SIDP members can also access the toolkit at the link below.

Disclaimer

Please keep in mind that information, data, and availability of mAbs in COVID-19 is constantly evolving. Use of SIDP guidelines and/or toolkits are intended as recommendations. Use does not supersede clinical judgement based on the assessment of an individual patient by an individual practitioner. The recommendations reflect the best available evidence at the time of publication and are not the sole resource for patient care management and/or an exclusive source of action.

SIDP COVID-19 Monoclonal Antibody Toolkit Taskforce Members

Special thanks to the following SIDP members for volunteering their time and efforts to the development of this toolkit:

  • Kristen Zeitler
  • Nicholas Piccicacco
  • Kyle Molina
  • Christina Koutsari
  • Sarah Minor
  • Oyejoke Fasoranti
  • Michael Casias
  • Yosef Nissim
  • Erin McCreary
  • Matthew Miller
  • Marissa Walsh
  • Kirthana Beaulac
  • Minkey Wungwattana
  • Larry Pineda
  • Eleanor Sadler

SIDP member, Kristen Zeitler, PharmD delivering COVID-19 mAb doses 

This toolkit was sponsored by unrestricted medical grants from Regeneron Pharmaceuticals, Inc. and AstraZeneca

Release Date 07/09/2021, Updated 1/1/2023



Society of Infectious Diseases Pharmacists • PO Box 1488, Warrenville, IL 60555
(331) 248-7888 • sidp@affinity-strategies.com
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software